Advisory Services Network, LLC Sage Therapeutics, Inc. Transaction History

Advisory Services Network, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$32.2 - $43.61 $96,922 - $131,266	3,010 New	3,010 $114,000
Q1 2021 May 24, 2021	SELL	$70.65 - $96.76 $35,325 - $48,380	-500 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$58.41 - $89.06 $3,270 - $4,987	56 Added 12.61%	500 $43,000
Q3 2020 Nov 16, 2020	BUY	$41.13 - $62.45 $18,261 - $27,727	444 New	444 $27,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.